Dr. Ball is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
10 Center Drive
Bethesda, MD 20892
Summary
- Dr. Mark Ball is a board-certified urologist in Bethesda, MD and is affiliated with National Institutes of Health Clinical Center. He received his medical degree from Johns Hopkins University School of Medicine and has been in practice 7 years. He specializes in minimally invasive surgery and surgical oncology and is experienced in kidney cancer, adrenal surgery, and retroperitoneal lymph node dissection.
Education & Training
- National Institutes of Health Clinical CenterFellowship, Urologic Surgical Oncology, 2016 - 2018
- Johns Hopkins UniversityResidency, Urology, 2011 - 2016
- Johns Hopkins UniversityInternship, Surgery, 2010 - 2011
- Johns Hopkins University School of MedicineClass of 2010
Certifications & Licensure
- MD State Medical License 2013 - 2026
- DC State Medical License 2017 - 2018
- American Board of Urology Urology
Awards, Honors, & Recognition
- Resident Teaching Award Department of Urology, Johns Hopkins University, 2016
- Alpha Omega Alpha Medical Honor Society 2015
- Member Alpha Omega Alpha, 2014
- Join now to see all
Clinical Trials
- A Phase II Study of Bevacizumab and Erlotinib in Subjects With Advanced Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC) or Sporadic Papillary Renal Cell Cancer Start of enrollment: 2010 May 06
- Robot-Assisted MRI-Guided Prostate Biopsy Start of enrollment: 2013 Jul 25
- Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma Start of enrollment: 2014 May 01
- Join now to see all
Publications & Presentations
PubMed
- 53 citationsImmune-checkpoint status in penile squamous cell carcinoma: a North American cohortMargaret Cocks, Diana Taheri, Mark W. Ball, Stephania M. Bezerra, Maria Del Carmen Rodriguez
Human Pathology. 2017-01-01 - 14 citationsMinority Enrollment in Phase II and III Clinical Trials in Urologic Oncology.Jeunice Owens-Walton, Cheyenne Williams, Alexis Rompré-Brodeur, Peter A Pinto, Mark W Ball
Journal of Clinical Oncology. 2022-05-10 - 818 citationsGenomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinomaDiana Miao, Claire A. Margolis, Wenhua Gao, Martin H. Voss, Wei Li
Science. 2018-02-16
Press Mentions
- Decision Making During Complex Partial Nephrectomy: A Guidelines-Based ApproachMarch 21st, 2021
- AUA 2018: Kidney Cancer Tumor BoardMay 19th, 2018
- SUO 2017: Results on Active Surveillance for Von Hippel-Lindau-Related Renal Tumors Using Size-Based Risk StratificationDecember 3rd, 2017
- Join now to see all
Grant Support
- Clinical Research GrantIntuitive Surgery2013–2014
- GrantSexual Medicine Society of North America2010–2012
Research History
- Fellow, Urologic OncologyLaboratory of W. Marson Linehan, MD. Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute2016 - 2018
- Research FellowJames Buchanan Brady Urological Institute2013 - 2014
Professional Memberships
- Member
- Member
- sexual medicine society of north americaMember
- Member
- Member
- Member
- Society of Urologic Oncology - SUOMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: